Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 18/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4760298 | 0.89 | CXCR4 (0.47) | CXCR4 | |
| SCHEMBL5054550 | 0.86 | CXCR4 (0.48) | CXCR4CHRM2ADRA2ACYP2D6DRD2 | |
| SCHEMBL5054546 | 0.86 | CXCR4 (0.48) | CXCR4CHRM2ADRA2ACYP2D6DRD2 | |
| SCHEMBL3263194 | 0.86 | CXCR4 (0.48) | CXCR4CHRM2ADRA2ACYP2D6DRD2 | |
| SCHEMBL30096632 | 0.86 | CXCR4 (0.48) | CXCR4CHRM2ADRA2ACYP2D6DRD2 | |
| Bromide SCHEMBL18628756 | 0.85 | CXCR4 (0.47) | CXCR4CHRM2ADRA2ACYP2D6DRD2 | |
| Hydrochloric Acid SCHEMBL18628724 | 0.85 | CXCR4 (0.47) | CXCR4CHRM2ADRA2ACYP2D6DRD2 | |
| SCHEMBL30667255 | 0.78 | CXCR4 (0.42) | CXCR4CYP2D6KCNH2 | |
| SCHEMBL1698240 | 0.78 | CXCR4 (0.45) | CXCR4CYP2D6KCNH2 | |
| SCHEMBL1698217 | 0.78 | CXCR4 (0.42) | CXCR4CYP2D6KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1465889-B1 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY | GENZYME CORP (US) | 2017-03-22 | — | — | EP | claimed |
| CN-113234104-B | Pincer-shaped molybdenum complex, preparation method thereof, catalytic composition, application and alcohol preparation method | 河北农业大学 | 2022-11-25 | — | — | CN | disclosed |
| CN-113185555-B | Pincer-shaped manganese complex and preparation method thereof, related ligand and preparation method thereof, catalyst composition and application | 河北农业大学 | 2022-11-11 | — | — | CN | disclosed |
| EP-1465889-B1 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY | GENZYME CORP (US) | 2017-03-22 | — | — | EP | disclosed |
| EP-1465889-A4 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY | ANORMED INC (CA) | 2008-05-14 | — | — | EP | disclosed |
| EP-1628533-A2 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY | ANORMED INC. (CA) | 2006-03-01 | — | — | EP | disclosed |
| WO-2004106493-A2 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY | ANORMED INC. (CA) | 2004-12-09 | — | — | WO | disclosed |
| EP-1465889-A1 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY | AnorMED Inc. (CA) | 2004-10-13 | — | — | EP | disclosed |
| WO-2003055876-A1 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY | ANORMED INC. (CA) | 2003-07-10 | — | — | WO | disclosed |